Denali Therapeutics Inc. (DNLI) › Shares OutstandingDenali Therapeutics Inc. (DNLI) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2017: 87.48M2018: 94.66M2019: 96.19M2020: 120.53M2021: 122.28M2022: 135.97M2023: 138.39M2024: 144.22M2025: 156.18M156.18M2017Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025156.18M+8.3%2024144.22M+4.2%2023138.39M+1.8%2022135.97M+11.2%2021122.28M+1.5%2020120.53M+25.3%201996.19M+1.6%201894.66M+8.2%201787.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share